Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02223247
Title A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors 3V Biosciences, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Scottsdale Arizona 85258 United States Details
Denver Colorado 80218 United States Details
Sarasota Florida 34232 United States Details
Oklahoma City Oklahoma 73104 United States Details
Nashville Tennessee 37203 United States Details
Dallas Texas 75390 United States Details
San Antonio Texas 78229 United States Details
Charthouse Square, London United Kingdom Details
London W1G 6AD United Kingdom Details
Manchester United Kingdom Details
West Smithfield, London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field